Screener
BioMarin Pharmaceuticals BMRN Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's gross profit?
- BioMarin Pharmaceuticals (BMRN) reported gross profit of $786.91M in Q2 2026.
- How has BioMarin Pharmaceuticals's gross profit changed year-over-year?
- BioMarin Pharmaceuticals's gross profit increased by 16.5% year-over-year, from $675.32M to $786.91M.
- What is the long-term trend for BioMarin Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's gross profit has grown at a 16.1% compound annual growth rate (CAGR), from $1.38B to $2.5B.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about BioMarin Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude